n****e
发帖数: 4990 | 1 现在有很多rumor，但是short intrest很高，如果爆的话，能量会很大。 |
c*****d
发帖数: 164 | 2 DNDN has a shitty prostate cancerdrug. Nobody uses it.
New better oral drugs coming out fast.
Provenge is a joke.
I do not think anybody in the right mind will buy it. |
s*******1
发帖数: 1644 | |
n****e
发帖数: 4990 | 4 the biggest drawback is the cost to make this drug. if bigger company
acquire them, the cost could drop a lot. win-win for both sides.
【在 c*****d 的大作中提到】
: DNDN has a shitty prostate cancerdrug. Nobody uses it.
: New better oral drugs coming out fast.
: Provenge is a joke.
: I do not think anybody in the right mind will buy it.
|
c*****d
发帖数: 164 | 5 no, even it is free, few will use it.
The benefit is so elusive: does not drop PSA or disease burden, only very
modest survival data (hard to convince patients or MD to use it)l
There are much better drugs now.
Stay away if not short it to zero. |
